Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Klement

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Molecular Cancer Research : MCR|November 16, 2018
Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor ImmunotherapyWei Xiao, Mohammed L Ibrahim, Priscilla S Redd, et al.
Cells|January 21, 2023
IRF8 Regulates Intrinsic Ferroptosis through Repressing p53 Expression to Maintain Tumor Cell Sensitivity to Cytotoxic T LymphocytesDakota B Poschel, Mercy Kehinde-Ige, John D Klement, et al.
Journal for Immunotherapy of Cancer|October 14, 2020
p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapyChunwan Lu, John D Klement, Alyssa D Smith, et al.
Cancer Research|April 7, 2017
SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor CellsPriscilla S Redd, Mohammed L Ibrahim, John D Klement, et al.
Molecular Cancer Therapeutics|November 25, 2024
STAT5 Activation Enhances Adoptive Therapy Combined with Peptide Vaccination by Preventing PD-1 InhibitionAaron E Fan, Hussein Sultan, Takumi Kumai, et al.
Journal for Immunotherapy of Cancer|July 30, 2021
WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escapeChunwan Lu, Zhuoqi Liu, John D Klement, et al.
The Journal of Clinical Investigation|November 6, 2018
An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasionJohn D Klement, Amy V Paschall, Priscilla S Redd, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Distinct and cooperative roles of host and tumor Osteopontin in colorectal cancer liver metastasisPatrick Czabala, Yang Zhao, John D Klement, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytesChunwan Lu, Dafeng Yang, John D Klement, et al.
Cell Reports|December 13, 2018
Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon TumorigenesisMohammed L Ibrahim, John D Klement, Chunwan Lu, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Molecular Cancer Research : MCR|November 16, 2018
Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor ImmunotherapyWei Xiao, Mohammed L Ibrahim, Priscilla S Redd, et al.
Cells|January 21, 2023
IRF8 Regulates Intrinsic Ferroptosis through Repressing p53 Expression to Maintain Tumor Cell Sensitivity to Cytotoxic T LymphocytesDakota B Poschel, Mercy Kehinde-Ige, John D Klement, et al.
Journal for Immunotherapy of Cancer|October 14, 2020
p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapyChunwan Lu, John D Klement, Alyssa D Smith, et al.
Cancer Research|April 7, 2017
SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor CellsPriscilla S Redd, Mohammed L Ibrahim, John D Klement, et al.
Molecular Cancer Therapeutics|November 25, 2024
STAT5 Activation Enhances Adoptive Therapy Combined with Peptide Vaccination by Preventing PD-1 InhibitionAaron E Fan, Hussein Sultan, Takumi Kumai, et al.
Journal for Immunotherapy of Cancer|July 30, 2021
WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escapeChunwan Lu, Zhuoqi Liu, John D Klement, et al.
The Journal of Clinical Investigation|November 6, 2018
An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasionJohn D Klement, Amy V Paschall, Priscilla S Redd, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Distinct and cooperative roles of host and tumor Osteopontin in colorectal cancer liver metastasisPatrick Czabala, Yang Zhao, John D Klement, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytesChunwan Lu, Dafeng Yang, John D Klement, et al.
Cell Reports|December 13, 2018
Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon TumorigenesisMohammed L Ibrahim, John D Klement, Chunwan Lu, et al.
Pageof 3